Serum lipid profiles and aggressive prostate cancer

Serum lipid profiles and aggressive prostate cancer

Bibliographic Details
Main Authors:	Yanjing Li, Chaozhao Liang, Jiaoti Huang
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-04-01
Series:	Asian Journal of Andrology
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2015;volume=17;issue=2;spage=336;epage=336;aulast=Li

Similar Items

Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer
by: Lingfan Xu, et al.
Published: (2019-01-01)

Serum lipids and prostate cancer
by: Garrido, M.M, et al.
Published: (2021)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
by: Julia Lipianskaya, et al.
Published: (2014-08-01)

Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy
by: Gui-Ming Zhang, et al.
Published: (2015-04-01)

Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
by: Juan Morote, et al.
Published: (2014-08-01)

Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer
by: Dingxiao Zhang, et al.
Published: (2016-02-01)

Association of prostate volume with incidence and aggressiveness of prostate cancer
by: Al-Khalil S, et al.
Published: (2016-10-01)

Profiling of metabolic biomarkers in the serum of prostate cancer patients
by: F. Ali, et al.
Published: (2020-02-01)

Neuroendocrine and Aggressive-Variant Prostate Cancer
by: Nicholas Spetsieris, et al.
Published: (2020-12-01)

Serum Lipid Profile in Iraqi patients with Breast Cancer
by: Faisal Gh. Al-Rubaye, et al.
Published: (2016-01-01)

THE CORRELATION BETWEEN SERUM PSA LEVEL AND PROSTATE HISTOLOGIC AGGRESSIVENESS WITH PROSTATIC VOLUME IN BPH PATIENTS
by: Gede Wirya Kusuma Duarsa, et al.
Published: (2019-01-01)

Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men
by: Shakira M. Nelson, et al.
Published: (2016-12-01)

Serum Lipid Profile In Xanthelasma
by: Gangopadadhya D N, et al.
Published: (1998-01-01)

Effects of RNA Binding Proteins on the Prognosis and Malignant Progression in Prostate Cancer
by: Xiaoliang Hua, et al.
Published: (2020-10-01)

Mitochondrial mutations drive prostate cancer aggression
by: Julia F. Hopkins, et al.
Published: (2017-09-01)

Blood-based biomarkers of aggressive prostate cancer.
by: Men Long Liong, et al.
Published: (2012-01-01)

Src: marker or actor of prostate cancer aggressiveness
by: Virginie eVlaeminck-Guillem, et al.
Published: (2014-08-01)

Extratumoral effects of highly aggressive prostate cancer
by: Strömvall, Kerstin
Published: (2017)

Obesity and Aggressive Prostate Cancer: Bias and Biology
by: McBride, Russell Bailey
Published: (2012)

The Role of Podocalyxin in Breast and Prostate Cancer Aggressiveness
by: Sizemore, Steven T.
Published: (2008)

Preoperative serum lipid profile and outcome in nonmetastatic colorectal cancer
by: Ting-Ting Hong, et al.
Published: (2016-12-01)

The role of developing breast cancer in alteration of serum lipid profile
by: Kamal Eldin A Abdelsalam, et al.
Published: (2012-01-01)

The Valuable Role of Measuring Serum Lipid Profile in Cancer Progression
by: Farahnaz Ghahremanfard, et al.
Published: (2015-09-01)

Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer
by: Jesse D Le, et al.
Published: (2014-08-01)

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
by: Rodolfo Montironi, et al.
Published: (2020-04-01)

Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients
by: Junfeng Xu, et al.
Published: (2020-02-01)

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
by: Yu Yin, et al.
Published: (2019-01-01)

Serum lipids profiles in psoriatic patients
by: Maryam Azizzadeh, et al.
Published: (2010-07-01)

Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway
by: Yu Yin, et al.
Published: (2019-06-01)

Reliability of multiparametric prostatic MRI quantitative data in the evaluation of prostate cancer aggressiveness
by: Haisam Atta, et al.
Published: (2017-09-01)

Serum lipid profile in patients with oral cancer and oral precancerous conditions
by: Rajul Mehta, et al.
Published: (2014-01-01)

Radiotherapy improves serum fatty acids and lipid profile in breast cancer
by: Sana Shaikh, et al.
Published: (2017-05-01)

Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA
by: Ce Wang, et al.
Published: (2019-04-01)

Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
by: Lucile Tallon, et al.
Published: (2014-07-01)

RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques
by: Jin-Guo Wang, et al.
Published: (2014-10-01)

Overexpression of periostin in stroma positively associated with aggressive prostate cancer.
by: Yuan Tian, et al.
Published: (2015-01-01)

Association of Serum Vitamin D Level and Serum Lipids Profile
by: Roxana Sadeghi, et al.
Published: (2018-04-01)

Fasting times in serum PSA assay
by: Xiang Xu, et al.
Published: (2014-10-01)

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput <i>N</i>-Glycan Profiling
by: Sarah Gilgunn, et al.
Published: (2020-12-01)

Symptomatic IgG4-Related Prostatitis Simultaneously Diagnosed with Aggressive Prostate Cancer
by: Taisuke Ezaki, et al.
Published: (2020-01-01)